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Summary
Objective: To evaluate the 2001 French burden of hospital primary joint replacement (PJR) for coxarthrosis and gonarthrosis.
Methods: Hospital surgical admissions for coxarthrosis and gonarthrosis in people aged over 40 years were selected from the French
National Hospital Database. Of the 73,150 and 58,746 admissions for coxarthrosis and gonarthrosis, respectively, only 96 and 73% of
them were analysed (exclusion of stays with no respect of coding guidelines). For each, we described the type of osteoarthritis, gender
and age group distribution, incidence rate of PJR adjusted on age and gender, the type of joint replacement (total vs partial), the type of
hospital (private vs hospital), the mean length of stay (LOS), the percentage of patients transferred to rehabilitation centre and the hospital
costs.
Results: Whatever the type of osteoarthritis, PJR was mainly performed for primary osteoarthritis, in the 71e80 years’ age group, in private
hospital, with a total replacement procedure. The mean LOS were 13 and 12 days, and the transfers to a rehabilitation centre were 33 and
44%, for hip and knee, respectively. The incident rate of PJR increased signiﬁcantly with age. It was higher in the 71e80 years’ age group and
decreased thereafter, whatever the gender and the type of osteoarthritis. The whole hospital costs were 591 and 411 millions of euros for hip
and knee, respectively.
Conclusion: The French National Hospital Database is a useful tool for assessing the burden of primary PJR for coxarthrosis and gonarthrosis.
It might be used for international comparisons.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis, a prevalent condition around the world, is
a most common cause of pain and disability, particularly
in ageing population, and is costly for patient as well as
for society. The burden of this disease has been recognized
by the United Nations and WHO, by endorsing the Bone
and Joint Decade 2000e20101. Osteoarthritis appeared
as a healthcare priority in the French public health program
with a peculiar attention to the disability and handicap re-
duction2. There is the strong need for nations to develop
their own system of information to evaluate and follow-up
the burden of this disease and especially of coxarthrosis
and gonarthrosis. In order to evaluate the burden of hip
and knee osteoarthritis in France, we analysed the available
data of surgical hospitalizations for primary joint replace-
ment (PJR) in patients with coxarthrosis and gonarthrosis,
extracted from the French National Hospital Database.
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SELECTION OF HOSPITAL ADMISSIONS
Hospital admissions were extracted from the 2001
French National Hospital Database (public and private hos-
pitals). For each hospitalization, according to the French
Health System Organization, each physician has to declare
all diagnoses and procedures performed, using the code of
the International Classiﬁcation of Disease, 10th revision
(ICD-10) and the French Catalogue of Procedures, respec-
tively. The National Hospital Database describes declara-
tive information and data were de-identiﬁed.
We selected all surgical admissions (elective and emer-
gency admissions) in women and men over 40 years, identi-
ﬁedby the codeof the principal diagnosis for coxarthrosis and
gonarthrosis (ICD-10 codes starting with M16 and M17,
respectively). In France, the principal diagnosis corresponds
to the disease which required the most important part of the
necessary medical and paramedical resources during
the hospital stay. We numbered 73,150 and 58,476 hospital
episodes for coxarthrosis and gonarthrosis, respectively.
We excluded the hospital stays for which the coding guide-
lines were not respected, i.e., the procedures were not in
adequacy with the localization of the osteoarthritis and the612
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In case of revision surgery, the principal diagnosis is either
a mechanical complication or a sepsis of the prosthesis. In
this case, osteoarthritis can be a secondary diagnosis only
in the case where this disease is present in a different joint.
We analysed 69,948 and 42,763 hospitalizations for primary
hip and knee replacement for osteoarthritis, respectively.
DESCRIPTIVE ANALYSIS
For each type of osteoarthritis, we described the number
of admissions, the type of osteoarthritis according to the de-
scription available with ICD-10 codes, the sex ratio (men/
women), the distribution in different age groups (41e50
years, 51e60 years, 61e70 years, 71e80 years and 81
years), the percentage of management in private hospitals,
the mean length of stay (LOS) for all admissions, by public
and private hospitals, the percentage of total joint replace-
ment, the percentage of transfer in rehabilitation centre after
hospitalization and hospital costs.
For each hospitalization, the medical information (diagno-
ses and procedures) classiﬁed a patient’s stay within a given
diagnosis-related group (DRG). DRG represented a med-
ico-economic entity concerning a set of diseases requiring
analogous management resources. These DRG were eval-
uated on the basis of data collected in a national study of
costs generated by a ‘‘reference’’ hospital patient sample,
while taking into account resource consumption for clinical
services (wages of physicians, nurses and other health pro-
fessionals involved, medical equipment depreciation and
maintenance, and logistics), resource consumption for
medico-technical services (laboratories, operating rooms,
functional examinations, dialyses, anaesthesia, emergency
units, radiotherapy, other medico-technical procedures,
medical consumables and drugs), individual expenses (ex-
penses directly allocated to patients and out-of-hospital pro-
cedures) and logistic expenses (catering, laundry services,
general logistics). We used the 2004 hospital tariffs per
DRG for hospital cost calculation, expressed in 2004V.
As longer LOS was cost consuming, we explored the im-
pact of several variables on LOS (i.e., age, gender, number
of secondary diagnoses, number of procedures, type of
hospital and transfer to rehabilitation centre). Each explan-
atory variable was dichotomized according to its median
value and introduced in a multivariate model (linear multiple
regression). The threshold of a P-value 0.20 in the univar-
iate study was retained for including the variables into the
multivariate model. Differences were considered signiﬁcant
when P< 0.05.
INCIDENT HOSPITAL RATES FOR PJR
We calculated the incident hospital rates (IC 95%) per
10,000 inhabitants for PJR for hip and knee osteoarthritis
using as numerator the number of admissions with joint re-
placement and as denominator the French population (data
from the last French census in 1999) adjusted for age group
and gender. The effect of age on PJR was studied using
a Chi-square test (a¼ 0.05).
Results
DESCRIPTIVE DATA
Table I describes the data of the 69,948 and 42,763 PJR
for coxarthrosis and gonarthrosis in France in 2001, respec-
tively. Hip primary replacement was carried out mainly forprimary osteoarthritis, in women, in patients aged from 71
to 80 years, in private hospital, with few transfers to rehabil-
itation centre. Similar results were observed for knee pri-
mary replacement, except for gender (sex ratio¼ 0.50)
and transfer to rehabilitation centre (44%).
The whole hospital cost was 1002 millions of euros of
which 59% was dedicated for coxarthrosis (Table I). The
mean costs were 8318 1233 and 7404 2537V, for hip
and knee, respectively.
Age (75 years), gender (women), number of secondary
diagnoses (1), number of procedures performed (4), and
transfer to rehabilitation centre appeared as signiﬁcantly im-
pacting on LOS, whatever the type of osteoarthritis (Table II).
INCIDENT RATES OF HOSPITALIZATION FOR PJR
Table III describes the incident rates of PJR adjusted on
age and gender for 10,000 inhabitants. The incidence rate
increased signiﬁcantly with age and decreased after 81
years of age, whatever the gender and the type of osteoar-
thritis (P< 0.0001).
Discussion
Our study is a retrospective evaluation of the hospitaliza-
tions for hip and knee osteoarthritis, based on the system-
atically declared data of hospital stays. We found that
PJR was mainly performed in the 71e80 years’ age group,
in private hospital, with a total replacement procedure,
whatever the type of osteoarthritis. The mean LOS were
13 and 12 days, and the transfers to rehabilitation centre
were 33 and 44% for hip and knee, respectively. The hospi-
tal cost for PJR was 1002 millions of euros of which 59%
was dedicated for hip osteoarthritis.
The quality control of hospital data is a crucial issue. In
France, two types of controls regarding the data quality
are performed: internal and external controls. Internal
Table I
Hospital descriptive data for primary joint replacement for coxarth-
rosis and gonarthrosis in France in 2001
Number of stays Coxarthrosis Gonarthrosis
69,948 42,763
Type of osteoarthritis (%)
Primary 74 64
With dysplasia 5 e
Post-traumatic 1 1
Secondary 3 11
Unspeciﬁed 17 24
Sex ratio (men/women) 0.82 0.50
Age-group (years, %)
41e50 5 1
51e60 14 7
61e70 29 27
71e80 40 53
81 12 12
Admission in private hospitals (%) 66 71
Total replacement (%) 92 85
LOS: day (mean standard
deviation)
13.0 5.5 12.1 6.3
Transfer to rehabilitation centre (%) 33 44
Hospital costs (V, 2004)
Total costs 590,611,602 410,466,507
Mean (standard deviation) 8318 (1233) 7404 (2537)
LOS: length of stay.
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Length of stay for surgical admissions (longer that 24 h) for coxarthrosis and gonarthrosis
Coxarthrosis Test t Linear multiple regression(
Variables Mean duration (days) Variables Estimate Standard error P
Modaly (A) (B) (A) (B) Intercept 11.8 0.05 <0.0001
Age <75 75 12.2 13.7* Age 75 1.32 0.04 <0.0001
Gender Men Women 12.7 13.3* Gender: men 0.45 0.04 <0.0001
SD <1 1 12.3 13.5* Nb of SD: 1 1.13 0.04 <0.0001
Rehabilitation Yes No 13.3 12.9* Rehabilitation: no 0.14 0.04 0.0016
Hospital Private Public 13.0 13.0 Type of hospital: public 0.15 0.04 0.0011
Procedures <4 4 13.0 13.0 Nb of procedures 4 0.10 0.04 0.013
Gonarthrosis Test t Linear multiple regression(
Variables Mean duration (days) Variables Estimate Standard error P
Modaly (A) (B) (A) (B) Intercept 10.23 0.07 <0.0001
Age <75 75 10.5 13.5* Age 75 2.59 0.05 <0.0001
Gender Men Women 11.2 12.7* Gender: men 0.98 0.05 <0.0001
SD <1 1 11.3 12.6* Nb of SD: 1 1.05 0.06 <0.0001
Rehabilitation Yes No 13.1 11.6* Rehabilitation: no 0.96 0.06 <0.0001
Hospital Private Public 12.2 11.9* Type of hospital: public 0.32 0.06 <0.0001
Procedures <4 4 12.12 12.1 Nb of procedures 4 0.16 0.05 0.004
*Univariate comparison of mean LOS, P< 0.001.(The variables introduced in the multivariate model were those which had a
P-value 0.20 in the univariate analysis.
yModal: modality of the variable considered, Nb: number, SD: secondary diagnosis.control is performed by each hospital prior to transmitting
the data to the authorities. The external control is performed
by the health authority ofﬁce. To date, the results of the in-
ternal and external controls are not published. Despite the
quality control (i.e., internal and external quality controls in
France) and the de-identiﬁed type of our data, we identiﬁed
remaining errors that led us to exclude some hospitaliza-
tions. Indeed, hospitalizations where the types of proce-
dures performed were not in accordance either with the
localization of osteoarthritis or with the ﬁrst occurrence of
joint replacement were not included. In the literature, this
aspect was assessed. The relevance of diagnosis of osteo-
arthritis in administrative database was compared to the
data of medical records. The positive predictive value for
deﬁnite and possible osteoarthritis was 78%3 and 89%4.
We focused on hospital admissions in people aged over
40 years. Indeed, hospitalizations in people aged 40 years
represented less than 2% of all hospitalizations for hip and
knee osteoarthritis in France, and similar data were estab-
lished in Iceland5, Sweden6 and Australia7. The aetiology
of the disease and the type of prosthesis ﬁxation deserved
further comments. Indeed, we can classify the type of oste-
oarthritis according to the ICD-10 codes. But, the information
is limited by the fact that ICD-10 codes do not provide all the
aetiologies of osteoarthritis; 18 to 25% of which are not spec-
iﬁed for hip and knee, respectively. So we might have under-
estimated the accurate aetiology of osteoarthritis managed
in French hospitals. For prosthesis, we can only describe
the type, total or partial, performed during the hospital stays.
Information related to the type of prosthesis ﬁxation (ce-
mented, cementless, hybrid or other) was not available.
A national register is available in other countries
such as Finland8, Sweden6,9,10, Norway11, Denmark12 and
Australia7e13. When we compared our data with other
papers analysing national data, some differences in the
description of the data were observed. The duration of
the data collection varied from 1 to 15 years5e7,11,12,14,15.
The data were more frequently issued from registers6e13
than from national hospital database5. The data focused
on hip joint replacement, except in Australia where theregister described data for knee replacement, as well7.
The quality control of the data was described and performed
in some countries7,11,16. The data described all joint
replacements performed whatever the diagnosis leading
to the prosthesis, and osteoarthritis represented above
75% of all diagnoses. The data allowed the description of
the type of prosthesis carried out (cemented, cementless,
hybrid or others6,7) with its context of primary prosthesis
or not, with the reason for revision. As our data were de-
identiﬁed, we cannot trace patients who underwent a contra-
lateral procedure during the same period. In Australia, for
example, the number of primary hip and knee replacements
were 19,637 and 19,881, of which 3.2 and 3.7% contralat-
eral procedures were performed during a 2-year period,
respectively7. This occurrence appeared low.
Table III
2001 incident rates of primary joint replacement* adjusted for age
and gender of stays [confidence interval 95%] for primary prosthe-
sis in coxarthrosis and gonarthrosis for 10,000 inhabitants in
France
Number of
primary prosthesis
Coxarthrosis Gonarthrosis
69,948 42,763
Women
41e50 years 2.96 [2.80e3.12] 0.72 [0.64e0.80]
51e60 years 12.82 [12.43e13.20] 6.04 [5.78e6.31]
61e70 years 34.96 [34.28e35.63] 24.83 [24.26e25.39]
71e80 years 64.31 [63.34e65.29] 58.43 [57.50e59.36]
81 years 39.83 [38.81e40.85] 25.71 [24.89e26.53]
Men
41e50 years 4.21 [4.02e4.40] 0.65 [0.57e0.72]
51e60 years 16.51 [16.07e16.95] 3.49 [3.29e3.70]
61e70 years 38.92 [38.16e39.68] 15.67 [15.19e16.15]
71e80 years 62.25 [61.12e63.39] 39.42 [38.52e40.33]
81 years 42.16 [40.59e43.73] 21.66 [20.53e22.78]
*Incident primary joint replacement: number of hospitalizations
for primary joint replacement divided by the French 1999 population
adjusted for age and gender.
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plain the LOS. Age, gender, number of secondary diagno-
ses, number of procedures, and rehabilitation after
hospitalization appeared as signiﬁcantly impacting on the
LOS. When we compared our results to other studies, for
example, for knee joint replacement, our mean duration of
stay appeared longer. Despite the fact that the data neces-
sary for adjustment are lacking for age, gender, type of data
selection and rules of coding and that the healthcare sys-
tem organization and funding was different, the mean
LOS varied for different centres. In the United States (4 cen-
tres), United Kingdom (6 centres) and Australia (2 centres),
the data analysed between September 1997 and December
1998 showed mean LOS of 4e6.1, 9.7e5.6, and 5.7e10.8
days, respectively17. In another study was outlined how the
DRG reimbursement is a much stronger determinant of
LOS18. Indeed, the developing cost reduction programs de-
creased hospital costs and LOS in a centre in United States
for total knee arthroplasty. The mean LOS decreased statis-
tically signiﬁcantly from 6.8 in 1992 to 4.2 in 1995. Health
system organization and funding is currently changing in
France and the described mean LOS might be decreased
according to the introduction of DRG reimbursement since
2004.
When we looked at the inpatients’ costs, few data were
available at country level. For example, Australia published
information related to the prevalence, costs and disease
burden. They used the Disease Costs and Impact Study
prevalence-based methodology to estimate the direct costs
of arthritis and especially of osteoarthritis, on the base year
1993e1994. Hospital inpatients’ costs represented 131.7
and 134.8 million dollars for public and private hospitals re-
spectively19. A recent review of the literature showed that
for 1997 the total expenditure on health per capita varied
between $400 and $4000 between different countries for
hip replacement20. The comparison of costs is difﬁcult to
perform, because of differences in demographics, type of
reporting, changes with time and speciﬁc healthcare system
organization and ﬁnancing.
Collecting data about hospitalizations for hip and knee
osteoarthritis, and especially for PJR, is important at a country
level to evaluate the burden of disease, the need of surgery
and to estimate the future demand for the procedure. There
is also a need for international harmonization of data collec-
tion, quality control and prospective and longitudinal follow-
up, which is important for international comparisons.
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